Quell and AstraZeneca entered a collaboration, exclusive option and license agreement in June 2023 to develop, manufacture and commercialize autologous, engineered Treg cell therapies for two ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

CAH is likely to acquire a majority stake in GI Alliance (“GIA”), along with acquiring the Advanced Diabetes Supply Group ...

Court Square Capital Partners has agreed to sell Advanced Diabetes Supply Group, a Carlsbad, California-based distributor of durable medical equipment specializing in diabetes supplies, to Cardinal ...

As Modern Healthcare reports, CMS has relaxed supervision requirements for physical and occupational therapist assistants from “direct” to “general.” The change could help health systems manage ...

Diabetes is an epidemic across the nation – the CDC reports it affects over 37 million Americans – and what is true ...

Cardinal Health has agreed to acquire a majority stake in GI Alliance, a gastroenterology management services organization, and Advanced Diabetes Supply Group for a combined total of $3.9 billion, ...

Dublin-based wholesale drug distribution and medical supplies company Cardinal Health is spending $3.9 billion on two ...

Drug distributor Cardinal Health said on Monday it will take a majority stake in gastroenterology care platform GI Alliance ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...